Steriscience Drug Patent Portfolio
Steriscience owns 1 orange book drug protected by 3 US patents Given below is the list of Steriscience's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11065256 | Administration and dosage of diaminophenothiazines | 11 Jan, 2039 | Active |
| US11065265 | Compositions of fosaprepitant and methods of preparation | 11 Jan, 2039 | Active |
| US12042504 | Injectable fosaprepitant composition | 11 Jan, 2039 | Active |
Latest Legal Activities on Steriscience's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Steriscience.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 20 Jul, 2021 | US11065265 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Jul, 2021 | US11065256 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Jul, 2021 | US11065256 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Jul, 2021 | US11065265 |
|
Email Notification
Critical
| 01 Jul, 2021 | US11065256 |
|
Email Notification
Critical
| 01 Jul, 2021 | US11065265 |
|
Issue Notification Mailed
Critical
| 30 Jun, 2021 | US11065256 |
|
Issue Notification Mailed
Critical
| 30 Jun, 2021 | US11065265 |
|
Email Notification
Critical
| 25 Jun, 2021 | US11065256 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 25 Jun, 2021 | US11065256 |
| Printer Rush- No mailing | 25 Jun, 2021 | US11065256 |
| Dispatch to FDC | 24 Jun, 2021 | US11065256 |
|
Response to Amendment under Rule 312
Critical
| 17 Jun, 2021 | US11065256 |
| Dispatch to FDC | 17 Jun, 2021 | US11065265 |
|
Application Is Considered Ready for Issue
Critical
| 17 Jun, 2021 | US11065265 |
Steriscience's Family Patents
Recent FDA approvals and tentative approvals for Steriscience
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Selenious Acid |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 28 Apr, 2025 |
Steriscience Drug List
Given below is the complete list of Steriscience's drugs and the patents protecting them.
1. Focinvez
Focinvez is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11065256 | Administration and dosage of diaminophenothiazines |
11 Jan, 2039
(13 years from now)
| Active |
| US11065265 | Compositions of fosaprepitant and methods of preparation |
11 Jan, 2039
(13 years from now)
| Active |
| US12042504 | Injectable fosaprepitant composition |
11 Jan, 2039
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Focinvez's drug page